In less than a month, from August 20 to September 19, amivantamab (Ami; Rybrevant, Johnson & Johnson) received 2 approvals ...

A French study found that follitropin alfa, a biosimilar fertility drug, is more cost-effective compared with its originator, ...

Average Medicare drug premiums for older Americans will drop next year for those enrolled in traditional Medicare plans or ...

Clyde Yancy, MD, MSc, FHFSA, professor, chief of cardiology, and vice dean of diversity and inclusion at Northwestern ...

Despite reductions in deaths from cancer and cardiovascular diseases, increased mortality from assaults, accidents, and the ...

Survey reveals gaps in vaccination intentions for flu, COVID-19, respiratory syncytial virus, and pneumococcal disease.

Systemic racism, including the practice of redlining, has had an enduring effect on health outcomes in people living with HIV ...

September marked Ovarian Cancer Awareness Month, highlighting the importance of early detection and the need for equitable ...

September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our ...

The innovative program from the Family Heart Foundation includes being able to order a free test kit for an at-home blood ...

While AI's role in clinical trial design and real-time monitoring is well-known, it also brings unprecedented potential in ...

Panelists discuss how HER2-directed therapies in non–small cell lung cancer (NSCLC) are evolving, with experts examining the distinction between HER2 mutation and expression, evaluating the efficacy ...